Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
37 studies found for:    Open Studies | Interventional Studies | cancer | vitamin e
Show Display Options
Rank Status Study
1 Recruiting Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.
Condition: Ovarian Cancer
Interventions: Drug: Cabazitaxel;   Drug: Tocotrienol
2 Recruiting The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients
Condition: Head and Neck Neoplasms
Interventions: Drug: Pentoxifylline;   Drug: Vitamin E;   Drug: Cisplatin;   Radiation: Radiation therapy
3 Recruiting Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Epirubicin 90 mg/m2 iv;   Drug: Cyclophosphamide 600 mg/m2 iv;   Drug: Docetaxel 100 mg/m2 iv OR paclitaxel 80 mg/m2 iv;   Drug: Trastuzumab 8 mg/kg iv saturation, then 6 mg/kg iv (HER2 positive patients only);   Drug: Pertuzumab 840 mg iv saturation, then 420 mg iv (selected HER2 positive patients only);   Dietary Supplement: Tocotrienol 300 mg x 3 daily
4 Recruiting Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan 165 mg/m2 iv;   Drug: Oxaliplatin 85 mg/m2 iv;   Drug: Calcium folinate 200 mg/m2 iv;   Drug: 5-fluorouracil 3200 mg/m2;   Dietary Supplement: Tocotrienol;   Drug: Placebo
5 Recruiting Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Bevacizumab;   Drug: Tocotrinol
6 Recruiting Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Day 1: Cisplatin 75 mg/m2;   Drug: Day 1: Vinorelbine 25 mg/m2;   Drug: Day 8: Capsule vinorelbine 50 mg/m2;   Drug: Day 1: Carboplatin AUC=5;   Drug: Day 1: Vinorelbine 30 mg/m2;   Drug: Day 8: Capsule vinorelbine 60 mg/m2;   Dietary Supplement: Tocotrienol 300 mg x 3 daily until progression;   Drug: Placebo 1 capsule x 3 daily until progression
7 Recruiting Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers
Condition: Non-small Cell Lung Cancers
Interventions: Radiation: stereotactic ablative radiotherapy (SABR);   Drug: Pentoxifylline
8 Not yet recruiting Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer
Conditions: Breast Carcinoma;   Fibrosis
Interventions: Other: skin-oriented spa care;   Drug: Pentoxifylline;   Drug: Tocopherol acetate
9 Recruiting Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis
Condition: Brain Metastasis
Interventions: Drug: Trental;   Dietary Supplement: Vitamin E
10 Recruiting DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor
Condition: Neuroendocrine Tumor
Interventions: Dietary Supplement: Vitamin supplement;;   Other: Diet advice
11 Not yet recruiting Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer
Condition: Cancer of Pancreas
Interventions: Dietary Supplement: Nutrawell Powder;   Other: Diet Only;   Dietary Supplement: OmegaRich fish oil supplement
12 Recruiting A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL
Conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma;   Mantle Cell Lymphoma
Interventions: Drug: TGR-1202;   Drug: Ibrutinib
13 Not yet recruiting Preoperative Radiotherapy and E7046 in Rectum Cancer
Condition: Neoadjuvant Therapy in Rectal Cancer
Interventions: Drug: E7046;   Radiation: Long Course Chemoradiotherapy (LCRT);   Radiation: Short Course Radiotherapy (SCRT);   Drug: capecitabine;   Drug: folinic acid/5-FU/oxaliplatin (mFOLFOX-6)
14 Recruiting Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Condition: BRAF V600E-mutant Metastatic Colorectal Cancer
Interventions: Drug: Encorafenib;   Drug: Binimetinib;   Drug: Cetuximab;   Drug: Irinotecan;   Drug: Folinic Acid;   Drug: 5-Fluorouracil
15 Recruiting Diet, Exercise and Vitamin D in Breast Cancer Recurrence
Condition: Breast Cancer
Interventions: Other: low Glycemic Index Mediterranean diet;   Other: Mediterranean diet;   Behavioral: Moderate physical activity;   Behavioral: Basic physical activity;   Dietary Supplement: high level Vitamin D;   Dietary Supplement: normal level Vitamin D
16 Recruiting Pharmacological Ascorbate for Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Ascorbic Acid
17 Recruiting Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer
Conditions: Cancer of Prostate;   Cancer of the Prostate;   Neoplasms, Prostate;   Neoplasms, Prostatic;   Prostate Cancer;   Prostate Neoplasms;   Prostatic Cancer
Interventions: Biological: androgen ablation (AA);   Biological: DC1 vaccine
18 Recruiting Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients
Condition: Rectal Cancer
Interventions: Drug: Capecitabine;   Drug: Oxaliplatin;   Drug: 5-fluorouracil;   Drug: Folinic Acid
19 Recruiting A Study of LY2801653 in Advanced Cancer
Condition: Cancer
Interventions: Drug: LY2801653;   Drug: Cetuximab;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Ramucirumab
20 Not yet recruiting A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   NSCLC
Interventions: Drug: Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Ascorbic Acid

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.